XBIT vs. IBB
Compare and contrast key facts about XBiotech Inc. (XBIT) and iShares Nasdaq Biotechnology ETF (IBB).
IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBIT or IBB.
Correlation
The correlation between XBIT and IBB is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
XBIT vs. IBB - Performance Comparison
Key characteristics
XBIT:
-0.19
IBB:
-0.21
XBIT:
0.34
IBB:
-0.17
XBIT:
1.04
IBB:
0.98
XBIT:
-0.19
IBB:
-0.13
XBIT:
-0.55
IBB:
-0.72
XBIT:
29.18%
IBB:
5.05%
XBIT:
85.72%
IBB:
17.38%
XBIT:
-92.67%
IBB:
-62.85%
XBIT:
-86.33%
IBB:
-24.60%
Returns By Period
In the year-to-date period, XBIT achieves a -6.08% return, which is significantly lower than IBB's -0.48% return.
XBIT
-6.08%
-46.62%
-43.45%
-25.80%
-29.70%
N/A
IBB
-0.48%
-3.65%
-10.90%
-3.79%
1.74%
2.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
XBIT vs. IBB — Risk-Adjusted Performance Rank
XBIT
IBB
XBIT vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XBIT vs. IBB - Dividend Comparison
XBIT has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.29%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBIT XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.29% | 0.29% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% |
Drawdowns
XBIT vs. IBB - Drawdown Comparison
The maximum XBIT drawdown since its inception was -92.67%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for XBIT and IBB. For additional features, visit the drawdowns tool.
Volatility
XBIT vs. IBB - Volatility Comparison
XBiotech Inc. (XBIT) has a higher volatility of 40.25% compared to iShares Nasdaq Biotechnology ETF (IBB) at 5.83%. This indicates that XBIT's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.